CN Patent

CN103619485B — 用于鼻腔药物递送的喷嘴

Assigned to Inbell Pharmaceutical Co · Expires 2017-08-08 · 9y expired

What this patent protects

本发明提供了一种用于递送气溶胶推进剂和药物制剂的混合物的喷嘴。所述喷嘴包括被构造来接纳气溶化推进剂和鼻内剂型的混合物的药品入口。所述入口设置在近端。喷嘴主体固定至所述药品入口。两个或更多个通道设置在所述主体内。两个或更多个孔口设置在所述喷嘴的远端。

USPTO Abstract

本发明提供了一种用于递送气溶胶推进剂和药物制剂的混合物的喷嘴。所述喷嘴包括被构造来接纳气溶化推进剂和鼻内剂型的混合物的药品入口。所述入口设置在近端。喷嘴主体固定至所述药品入口。两个或更多个通道设置在所述主体内。两个或更多个孔口设置在所述喷嘴的远端。

Drugs covered by this patent

dihydroergotamine-mesylate (DIHYDROERGOTAMINE MESYLATE)

Patent Metadata

Patent number: CN103619485B
Jurisdiction: CN
Classification: —
Expires: 2017-08-08
Drug substance claim: No
Drug product claim: No
Assignee: Inbell Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.